This new edition focuses on recent developments that are reflected by an impressive addition to the scientific literature. This fifth edition retains key elements that have made the success of previous editions: world-wide contributors, variety of topics covered, presentation of key aspects using workplace scenarios and case histories.
Asthma can be caused and aggravated by occupational factors in working adults. Agents that are responsible for occupational asthma are either sensitizers or irritants. Prevention is important to reduce the impact of the disease. This new edition of Asthma in the Workplace focuses on recent developments that are reflected by an impressive addition to the scientific literature. This fifth edition retains key elements that have made the success of previous editions: world-wide contributors, variety of topics covered, presentation of key aspects using workplace scenarios and case histories. This new comprehensive edition is intended to be of interest for health professionals, researchers, students, practitioners and various professionals involved in the assessment and management of workers exposed to occupational factors that may cause or exacerbate asthma.
Key Features
Comprehensive coverage of all aspects of work-related asthma, including historical aspects, epidemiology and risk factors, mechanisms and genetics, other types of work-related asthma conditions and variants, hypersensitivity pneumonitis, occupational urticaria and dermatitisAssessment of the worker and workplace along with management of the worker, prevention and medicolegal aspectsOf interest not only to pulmonologists, but also for industrial hygienists, researchers, lawyers and other health professionals in the field of work-related conditionsDetailed information about specific agents, including a variety of high- and low-molecular weight agents
Preface |
|
ix | |
Editors |
|
xiii | |
Contributors |
|
xv | |
|
|
|
1 Definition and Classification of Asthma in the Workplace |
|
|
3 | (6) |
|
|
|
|
|
2 Historical Aspects of Occupational Asthma |
|
|
9 | (6) |
|
|
|
|
|
3 Disease Occurrence and Risk Factors |
|
|
15 | (20) |
|
|
|
|
|
|
4 Mechanisms, Genetics, and Pathophysiology |
|
|
35 | (22) |
|
|
|
|
|
|
|
|
|
|
|
5 Assessment of the Worker |
|
|
57 | (10) |
|
|
|
|
|
|
|
|
6 Assessment of the Workplace |
|
|
67 | (14) |
|
|
|
|
|
|
|
7 Immunological and Inflammatory Assessments |
|
|
81 | (8) |
|
|
|
|
|
|
|
89 | (16) |
|
|
|
|
|
|
|
|
|
9 Management of the Worker |
|
|
105 | (6) |
|
|
|
|
|
|
111 | (12) |
|
|
|
|
|
|
11A Impairment and Disability Evaluations |
|
|
123 | (14) |
|
|
|
|
|
|
|
|
|
11B Impairment and Disability Evaluations |
|
|
137 | (16) |
|
|
|
|
|
|
|
|
|
PART IV SPECIFIC AGENTS CAUSING IMMUNOLOGICAL OCCUPATIONAL ASTHMA |
|
|
|
12 Occupational Asthma in the Baking Industry |
|
|
153 | (12) |
|
|
|
|
|
|
13 Asthma and Allergy to Animals, Fish, and Shellfish |
|
|
165 | (14) |
|
|
|
|
|
14 Polyisocyanates and Their Prepolymers |
|
|
179 | (16) |
|
|
|
|
|
|
15 Western Red Cedar and Other Wood Dusts |
|
|
195 | (12) |
|
|
|
|
|
|
207 | (10) |
|
|
|
|
|
|
|
217 | (12) |
|
Jolanta M. Walusiak-Skorupa |
|
|
|
|
|
|
|
|
18 Various High- and Low-Molecular-Weight Agents |
|
|
229 | (22) |
|
|
|
|
|
|
|
|
|
PART V SPECIFIC DISEASE ENTITIES AND VARIANTS |
|
|
|
19 Irritant-Induced Asthma and Reactive Airways Dysfunction Syndrome |
|
|
251 | (10) |
|
|
|
|
|
|
20 Asthma Exacerbated at Work |
|
|
261 | (12) |
|
|
|
|
|
|
21 Eosinophilic Bronchitis |
|
|
273 | (6) |
|
|
|
|
|
|
|
279 | (14) |
|
|
|
|
23 Airway Diseases Due to Organic Dust Exposure |
|
|
293 | (10) |
|
|
|
|
|
|
|
|
24 Occupational Hypersensitivity Pneumonitis and Organic Dust Toxic Syndrome |
|
|
303 | (8) |
|
|
|
|
|
|
|
|
25 Chronic Obstructive Airway Disease Due to Occupational Exposure |
|
|
311 | (10) |
|
|
|
|
|
26 Building-Related Illnesses and Mold-Related Conditions |
|
|
321 | (12) |
|
|
|
|
|
27 Occupational Urticaria and Allergic Contact Dermatitis |
|
|
333 | (12) |
|
|
|
|
|
Index |
|
345 | |
Susan M. Tarlo, Professor of Medicine, University Health Network and St Michaels Hospital, Toronto; Department of Medicine, University of Toronto, Ontario, Canada
Olivier Vandenplas, Professor of Medicine, Head Department of Chest Medicine, Centre hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium
David I. Bernstein, Professor Emeritus of Medicine, Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Jean-Luc Malo, Professor of Medicine (retired), Hōpital du Sacré-Coeur de Montréal and Université de Montréal, Montréal, Canada